CN112120204A - Sweet composition for reducing blood fat and preparation method thereof - Google Patents

Sweet composition for reducing blood fat and preparation method thereof Download PDF

Info

Publication number
CN112120204A
CN112120204A CN202011161827.2A CN202011161827A CN112120204A CN 112120204 A CN112120204 A CN 112120204A CN 202011161827 A CN202011161827 A CN 202011161827A CN 112120204 A CN112120204 A CN 112120204A
Authority
CN
China
Prior art keywords
extract
cyclocarya paliurus
composition
parts
blood fat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202011161827.2A
Other languages
Chinese (zh)
Inventor
李伟
黄华学
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hunan Huacheng Biotech Inc
Original Assignee
Hunan Huacheng Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hunan Huacheng Biotech Inc filed Critical Hunan Huacheng Biotech Inc
Priority to CN202011161827.2A priority Critical patent/CN112120204A/en
Publication of CN112120204A publication Critical patent/CN112120204A/en
Priority to PCT/CN2021/074139 priority patent/WO2022088540A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/30—Artificial sweetening agents
    • A23L27/33—Artificial sweetening agents containing sugars or derivatives
    • A23L27/36—Terpene glycosides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/30—Artificial sweetening agents
    • A23L27/33—Artificial sweetening agents containing sugars or derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/30—Artificial sweetening agents
    • A23L27/33—Artificial sweetening agents containing sugars or derivatives
    • A23L27/34—Sugar alcohols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/30—Artificial sweetening agents
    • A23L27/33—Artificial sweetening agents containing sugars or derivatives
    • A23L27/38—L-sugars
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/52—Juglandaceae (Walnut family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Botany (AREA)
  • Birds (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Seasonings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention relates to a blood fat reducing sweet taste composition which comprises a filling type sweetener, dietary fiber, protein powder, a sucrose substitute, a momordica grosvenori extract and a cyclocarya paliurus extract. On one hand, the existence of the mogroside V can effectively inhibit the bad taste of the cyclocarya paliurus extract, and on the other hand, the existence of the mogroside V can also improve the blood fat reducing effect of the cyclocarya paliurus extract. The raw materials of the sweet composition provided by the invention are derived from natural plants or microbial fermentation, do not contain chemical synthetics, are green, environment-friendly and safe, have no toxic or side effect, can replace sucrose, and can not bring adverse consequences such as blood sugar rise, obesity, decayed teeth and the like caused by the sucrose. Not only can provide good sweetness and sweetness, maintains the good flavor and physiological action of each component, but also has the functions of sugar replacement, sugar special for diabetics, anti-obesity agent, anti-three-high health-care food and the like.

Description

Sweet composition for reducing blood fat and preparation method thereof
Technical Field
The invention relates to a sweet composition, and in particular relates to a sweet composition for reducing blood fat and a preparation method thereof.
Background
The sweetener is a food additive that imparts sweetness to foods and is a food additive that is consumed in the largest amount worldwide. According to the nature of the sweetener, the sweetener can be divided into three categories: the first is chemically synthesized sweeteners such as saccharin, cyclamate, acesulfame potassium, aspartame, sucralose, neotame, and the like. The second type is natural sweetener, such as glycyrrhizin, stevioside, mogroside, rubusoside, etc. The third type is functional sweetener, such as sugar alcohol, oligosaccharide, etc. Because various sweetener monomers can not simultaneously meet four requirements of safety, taste, process and cost, and have defects in different aspects and different degrees, the mutual defects can be made up and the advantages of the sweetener can be exerted through compounding, and therefore the compound sweetener is produced at the same time.
Because the taste and texture of each sweetener are different from those of cane sugar, and bad flavor and aftertaste are generated when the dosage is large, the bad parts can be overcome by using the compound sweetener. The sweetening agent has synergistic effect after being compounded, thereby not only eliminating bitter and astringent taste, but also improving sweetness. The sweetness is improved, and the taste and flavor are corrected and improved by utilizing the synergistic effect of more than two monomer sweeteners and other substances.
The high-power sweetener has advantages and disadvantages in sweetness, mouthfeel and stability, is usually used in a compounding way and can complement each other, and has the advantages of improving mouthfeel and flavor, reducing aftertaste, improving sweetness, reducing the using amount of the sweetener and improving economic benefit. With the gradual population aging of the society in recent years, the health concepts of controlling over-nutrition and reducing high fat, high sugar and high salt are further emphasized, and the low-calorie compound sweetener is rapidly developed.
Nowadays, the productivity is rapidly developed, the social living standard is increasingly improved, and the requirements of people on sweet substances or sweeteners are gradually sublimated to healthy sweet from 'pure sweet' to 'safe sweet' from the beginning. However, the compound sweetener or the sweet taste composition only pays attention to 'zero sucrose' and 'zero calorie', and the increasingly-rising nutritional and health-care requirements of consumers are mostly ignored.
CN106659203A discloses an improved sweetener consisting essentially of allulose and at least one steviol glycoside.
CN107995845A discloses a sweetening composition containing rebaudioside D, consisting essentially of rebaudioside D and dextrose, D-psicose, fructose, isomalt, erythritol, hydrogenated isomaltulose, hydrogenated starch hydrolysate, lactitol, maltitol, mannitol, polydextrose, sorbitol, sucrose, trehalose, xylitol and combinations thereof as a carrier.
CN105338827A discloses a composition and a food comprising D-psicose and erythritol and at least one component selected from rebaudioside a, rebaudioside B, rebaudioside C, rebaudioside D, rebaudioside E, rebaudioside M, sucrose, monatin, thaumatin, monellin, brazzein, L-alanine, glycine, luo han guo, mogroside, hernandulcin, phyllodulcin, trilobatin.
CN103906437A discloses a sweet taste composition for alleviating diabetes, comprising D-psicose and slowly digestible or indigestible polysaccharide as active ingredients, further comprising a high intensity sweetener. The slowly digestible polysaccharide or the digestion resistant polysaccharide comprises at least one polysaccharide selected from the group consisting of palatinose, trehalose, digestion resistant maltodextrin, and oligosaccharides; the high intensity sweetener comprises at least one high intensity sweetener selected from the group consisting of steviol glycosides, sucralose, aspartame, luo han guo extract, licorice extract, thaumatin, and agave syrup.
The sweetener and sweetening compositions of the above publications generally have no nutritional, health-promoting effect other than the "sweet" effect, or have only a limited blood glucose suppression, with no other health-promoting effect.
Cyclocarya paliurus, also called Qingqian plum, cyclocarya paliurus, salix caprae, sweet tea tree and the like, belongs to juglandaceae plants, is a medicinal plant, and has the effects of clearing away summer-heat, reducing blood pressure, tonifying heart, improving immunity, prolonging life and the like. For a long time, the tea is made by adopting tender leaves of the tea in folks, has the effects of reducing blood sugar, stabilizing sugar, promoting the production of body fluid, quenching thirst, clearing away summer heat, reducing blood pressure, strengthening heart and prolonging life, is known as blood sugar-reducing tea, and can effectively prevent and treat diseases such as diabetes, hypertension, coronary heart disease, neurasthenia and the like. The cyclocarya paliurus extract contains flavonoids, triterpenes, saponins, organic acid compounds and inorganic elements necessary for human bodies. However, the cyclocarya paliurus extract has unpleasant tastes such as bitter taste and sour and astringent taste due to the extraction process, so the cyclocarya paliurus extract is rarely used as a component in a sweetener and is generally used as a component in a tea beverage.
The momordica grosvenori belongs to cucurbitaceae plants, is a traditional Chinese medicinal and edible plant, and has the effects of clearing heat, moistening lung, lubricating intestines, relaxing bowels and promoting intestines and stomach. The fruit has high nutritive value, and is rich in vitamin C, glycoside, fructose, glucose, protein, lipid, etc., wherein the mogroside, which is a non-sugar triterpene component with strong sweet taste, is the main effective component of fructus Siraitiae Grosvenorii.
CN102960520A discloses an L-arabinose health-care tablet sugar added with cyclocarya paliurus, but the compounding of cyclocarya paliurus powder and L-arabinose cannot obtain a sweet product with satisfactory mouthfeel.
In the prior art, mogroside V is often used as a high-power sweetener in a sweet taste composition, so that the use amount of sugar can be obviously reduced, the sugar intake of a human body is reduced, and the mogroside V is a healthy sweetener for replacing sucrose. But its beneficial physiological activity for the human body is still somewhat insufficient.
CN105558191A discloses a compound tea of momordica grosvenori cyclocarya paliurus extract, which is prepared by respectively extracting momordica grosvenori pericarp, momordica grosvenori seeds and cyclocarya paliurus leaves as raw materials to obtain momordica grosvenori pericarp extract powder, and uniformly mixing the momordica grosvenori seed extract powder and the cyclocarya paliurus leaf extract powder. It tastes astringent and bitter and is not suitable as a sweetener product.
CN106176953A discloses a blood sugar-reducing health-care composition containing cyclocarya paliurus leaves, momordica grosvenori and mulberry leaves, which has a certain health-care effect of reducing high blood pressure, high blood sugar and high blood sugar. But it is not good in taste and is not suitable as a sweetener product.
Therefore, a sweet composition which has good taste and has certain beneficial physiological activity is sought, can make up for the blank of the market, and has great research significance and economic value.
Disclosure of Invention
The technical problem to be solved by the invention is to overcome the problems in the prior art, and provide a sweet composition with various nutritional and health-care effects, which can reduce hypertension, hyperlipidemia and hyperglycemia, and particularly has an excellent effect on reducing blood fat.
The technical scheme adopted by the invention for solving the technical problems is as follows: a sweet taste composition for reducing blood lipid comprises filled sweetener, dietary fiber, protein powder, sucrose substitute, fructus Siraitiae Grosvenorii extract and cyclocarya paliurus extract.
The mass content of mogroside V in the fructus momordicae extract is more than 40%, and the mass content of cyclocarya paliurus total glycosides in the cyclocarya paliurus extract is more than 70%.
The fructus Siraitiae Grosvenorii extract and cyclocarya paliurus extract are independently used in the blood lipid reducing sweet composition at a content of 1-5 wt%; preferably, the blood fat reducing sweet composition of the momordica grosvenori extract accounts for 2-3.5 wt%, and the blood fat reducing sweet composition of the cyclocarya paliurus extract accounts for 1.4-2.6 wt%.
More preferably, the mass ratio of the momordica grosvenori extract to the cyclocarya paliurus extract in the composition is 1:0.6-1.4, preferably 1: 0.8-0.9.
The fructus momordicae extract is derived from natural resources peculiar to China, and is a medicine-food homologous plant, namely fructus momordicae, and has the advantages of high sweetness multiple, long sweet feeling time, no aftertaste and other abnormal flavors, zero calorie, no increase of blood sugar level and the like. The cyclocarya paliurus extract is derived from rare tree species which only survive in China and glacier in the quaternary, is known as panda in the plant world, namely cyclocarya paliurus, has the functions of reducing blood pressure, blood sugar and blood fat, and has unique effects of enhancing human immunity, resisting oxidation and aging and protecting liver.
The inventor unexpectedly finds that the momordica grosvenori extract and the cyclocarya paliurus extract are compounded, so that the momordica grosvenori glycoside V can effectively inhibit the bad taste of the cyclocarya paliurus extract, and the momordica grosvenori extract can improve the blood fat reducing effect of the cyclocarya paliurus extract.
The bulk sweetener is selected from at least one of isomaltulose, trehalose, sorbitol, xylitol, mannitol, maltitol, isomalt, lactitol and erythritol; the sucrose substitute is at least one selected from arabinose, psicose, xylose, deoxyribose, sorbose, tagatose, mannose, galactose, talose, fucose, rhamnose, sedoheptulose, and mannoheptulose.
As a preferred technical scheme of the present invention, the sweet taste composition provided by the present invention comprises the following raw materials: erythritol, dietary fiber, protein powder, fructus momordicae extract, cyclocarya paliurus extract, arabinose and psicose.
Further, the sweet taste composition comprises the following raw materials in parts by weight: 10-30 parts of erythritol, 10-20 parts of dietary fiber, 8-15 parts of protein powder, 1-2 parts of a momordica grosvenori extract, 1-2 parts of a cyclocarya paliurus extract, 1-5 parts of arabinose and 1-5 parts of allulose.
The erythritol has the characteristics of low sweetness, high stability, high dissolution heat, high solubility, low hygroscopicity and the like, and has the main effects of diluting the sweetness of the momordica grosvenori extract with high sweetness multiple, almost zero heat and cool mouthfeel.
The arabinose has the effects of inhibiting sucrose absorption, controlling blood sugar elevation, preventing constipation, etc.
The psicose has the characteristic of sugar substitution, and has the nutritional health-care effects of enhancing insulin resistance, inhibiting postprandial blood sugar increase, reducing fat accumulation in abdomen, preventing diabetes and the like.
The dietary fiber can not be digested and absorbed by gastrointestinal tract, can not generate energy, and has effects of resisting diarrhea, preventing diseases, reducing blood lipid, reducing blood sugar, and controlling body weight.
The protein powder has effects of supplementing nutrient source, preventing diseases, and relieving kidney burden. The protein powder comprises soybean protein, casein, whey protein and pea protein.
In the invention, the combination of the momordica grosvenori extract, the cyclocarya paliurus extract, the erythritol, the arabinose, the psicose, the dietary fiber and the protein powder not only can provide good sweetness and sweetness, keeps good flavor and physiological action of each component, but also has the effects of sugar substitution, sugar special for diabetics, anti-obesity agent, anti-three-high health-care food and the like.
The second purpose of the invention is to provide a preparation method of the sweet taste composition, which comprises the following steps:
(1) and (3) dry granulation: mixing erythritol, dietary fiber and protein powder at a certain proportion, pulverizing, sieving, mixing, and granulating with dry granulating machine;
(2) preparation of the adhesive: mixing fructus Siraitiae Grosvenorii extract, cyclocarya paliurus extract, arabinose, and psicose at a certain proportion, dissolving in hot water, filtering with ceramic membrane, vacuum concentrating the filtrate under reduced pressure, and keeping the temperature to obtain binder;
(3) boiling and granulating: putting the mixture particles obtained in the step (1) into a fluidized bed of a boiling granulator, starting a fan and heating; spraying the adhesive in the step (2), and keeping the materials in the fluidizing chamber to be boiled and mixed to make the materials uniform; after the spraying of the adhesive is finished, the mixture is dried by heat preservation, stopped and kept stand for cooling, and the sweet composition is obtained.
Further, in the step (1), the mesh number of the sieve is 80-200 meshes.
Further, in the step (2), the amount of the hot water is 10-20 times of the total mass of the momordica grosvenori extract, the cyclocarya paliurus extract, the arabinose and the psicose; the temperature of the hot water is 60-80 ℃; the aperture of the ceramic membrane is 0.5-10 mu m; the vacuum reduced pressure concentration conditions comprise: the temperature is 60-80 ℃, the vacuum degree is-0.07-0.09 MPa, and the concentration is carried out until the solid content is 20-40%; the temperature for heat preservation is 90-100 ℃, and the time is 1-2 hours. In the invention, one of the purposes of high-temperature heat preservation is to enable the components to interact with each other so as to exert the synergistic effect; the second purpose is sterilization.
Further, in the step (3), the heating temperature is 100-120 ℃, and the mixing time is 30-60 min. In the invention, the heat preservation, drying and standing cooling can be realized by a boiling granulator.
In the invention, firstly, a dry granulation mode is used, and the erythritol, the dietary fiber and the protein powder which are more in parts by mass and different in solubility in the composition are prepared into mixture particles, so that the erythritol, the dietary fiber and the protein powder are uniformly distributed, and fluidized bed particles with good fluidity are provided for a subsequent boiling granulation step. The purpose of the subsequent boiling granulation is to make the main sweet component (the mass part in the composition is less) in the adhesive uniformly contact with the mixture granules, and finally, the purpose of stable and uniform distribution of various components in the composition is achieved.
The sweet composition prepared by the preparation method can be stored for a long time, has stable quality and low moisture rate.
Compared with the prior art, the invention has the following beneficial effects:
(1) the raw materials of the sweet composition provided by the invention are derived from natural plants or microbial fermentation, do not contain chemical synthetics, are green, environment-friendly and safe, have no toxic or side effect, can replace sucrose, and can not bring adverse consequences such as blood sugar rise, obesity, decayed teeth and the like caused by the sucrose.
(2) The sweet composition provided by the invention not only can provide good sweetness and sweetness, keeps good flavor and physiological action of each component, but also has the effects of sugar substitutes, sugar special for diabetics, anti-obesity agents, anti-three-high health-care food and the like.
(3) According to the sweet composition provided by the invention, the momordica grosvenori extract and the cyclocarya paliurus extract play a synergistic effect, so that the blood fat reducing effect of the cyclocarya paliurus extract is improved.
(4) The production process is stable, the equipment is simple, the environment is protected, the safety is realized, the pollution is avoided, and the method is suitable for large-scale production.
(5) The sweet composition can be applied to dairy products, foods, medicines, seasonings, health-care products, cosmetics, essences and spices.
Detailed Description
The present invention will be described in detail below by way of examples. In the following examples of the present invention,
the dry granulator and the boiling granulator are both purchased from Changzhou city step drying equipment Limited company;
ceramic membranes were purchased from Nanjing Fulinde environmental protection science and technology, Inc.;
measuring the content of mogroside V in fructus Siraitiae Grosvenorii extract by High Performance Liquid Chromatography (HPLC) external standard method;
the content of cyclocarya paliurus total glycosides in the cyclocarya paliurus extract is measured by a spectrophotometry method;
the fructus Siraitiae Grosvenorii extract and cyclocarya paliurus extract are from Hainan Cheng biological resource GmbH of lake; the process for extracting the momordica grosvenori extract can refer to the method described in the previous patents CN201410357838.6 (mogroside V content > 60%) and CN201711064166.X (40% < mogroside V content < 60%) of the applicant, and the process for extracting the cyclocarya paliurus extract refers to the method described in CN 201911267286.9.
Other materials are commonly commercially available unless otherwise specified.
Example 1
A method of preparing a sweet tasting composition comprising the steps of:
(1) and (3) dry granulation: mixing 20 parts of erythritol, 20 parts of dietary fiber (soybean dietary fiber) and 10 parts of protein powder (whey protein), crushing, sieving, uniformly mixing, and preparing a mixture of the erythritol, the dietary fiber and the protein powder into mixture particles by using a dry granulator;
(2) preparation of the adhesive: mixing 2 parts of fructus Siraitiae Grosvenorii extract (containing mogroside V50.5%), 1.5 parts of cyclocarya paliurus extract (containing total glycosides of cyclocarya paliurus 80.1%), 2 parts of arabinose, and 3 parts of psicose, dissolving in hot water 10 times of the total weight of the above four components at 80 deg.C, filtering with ceramic membrane with pore diameter of 1 μm, and vacuum concentrating the filtrate at 80 deg.C and vacuum degree of-0.07 MPa until the solid content of the concentrated solution is 25%. Preserving the temperature of the concentrated solution for 2 hours at the temperature of 90 ℃ to obtain an adhesive;
(3) boiling and granulating: putting the mixture particles obtained in the step (1) into a fluidized bed of a boiling granulator, starting a fan and heating to 110 ℃; spraying the adhesive in the step (2), keeping the materials in the fluidizing chamber boiling, and mixing for 50min to make the materials uniform; after the spraying of the adhesive is finished, the mixture is dried by heat preservation, stopped and kept stand for cooling, and the sweet composition is obtained.
Example 2
A method of preparing a sweet tasting composition comprising the steps of:
(1) and (3) dry granulation: mixing raw materials of 15 parts of erythritol, 30 parts of dietary fiber (soybean dietary fiber) and 15 parts of protein powder (whey protein), crushing, sieving, uniformly mixing, and preparing a mixture of the raw materials, the dietary fiber (soybean dietary fiber) and the protein powder into mixture particles by using a dry granulator;
(2) preparation of the adhesive: mixing 2 parts of fructus Siraitiae Grosvenorii extract (containing mogroside V50.5%), 1 part of cyclocarya paliurus extract (containing total glycosides of cyclocarya paliurus 80.1%), 4 parts of arabinose, and 2 parts of psicose, dissolving in hot water 20 times of the above four components at 60 deg.C, filtering with ceramic membrane with aperture of 1 μm, and vacuum concentrating the filtrate at 80 deg.C and vacuum degree of-0.07 MPa until the solid content of the concentrated solution is 20%. Preserving the heat of the concentrated solution for 1.5 hours at the temperature of 95 ℃ to obtain an adhesive;
(3) boiling and granulating: putting the mixture particles obtained in the step (1) into a fluidized bed of a boiling granulator, starting a fan and heating to 105 ℃; spraying the adhesive in the step (2), keeping the materials in the fluidizing chamber boiling, and mixing for 60min to make the materials uniform; after the spraying of the adhesive is finished, the mixture is dried by heat preservation, stopped and kept stand for cooling, and the sweet composition is obtained.
Example 3
The other conditions and operations were the same as in example 2 except that the amount of cyclocarya paliurus extract was changed to 1.2 parts.
Example 4
A method of preparing a sweet tasting composition comprising the steps of:
(1) and (3) dry granulation: mixing raw materials of 30 parts of erythritol, 15 parts of dietary fiber (soybean dietary fiber) and 10 parts of protein powder (whey protein), crushing, sieving and uniformly mixing, and preparing a mixture of the raw materials, the dietary fiber (soybean dietary fiber) and the protein powder into mixture particles by using a dry granulator;
(2) preparation of the adhesive: mixing 1.5 parts of fructus Siraitiae Grosvenorii extract (containing mogroside V60.9%), 1 part of cyclocarya paliurus extract (containing total glycosides of cyclocarya paliurus 72.7%), 2 parts of arabinose, and 3 parts of psicose, dissolving in hot water 15 times of the total weight of the above four components at 70 deg.C, filtering with ceramic membrane with pore diameter of 1 μm, and vacuum concentrating the filtrate at 70 deg.C and vacuum degree of-0.08 MPa until the solid content of the concentrated solution is 20%. Preserving the heat of the concentrated solution for 1 hour at the temperature of 100 ℃ to obtain an adhesive;
(3) boiling and granulating: putting the mixture particles obtained in the step (1) into a fluidized bed of a boiling granulator, starting a fan and heating to 105 ℃; spraying the adhesive in the step (2), keeping the materials in the fluidizing chamber boiling, and mixing for 60min to make the materials uniform; after the spraying of the adhesive is finished, the mixture is dried by heat preservation, stopped and kept stand for cooling, and the sweet composition is obtained.
Comparative example 1
The other conditions and operations were the same as in example 2 except that no Momordica grosvenori extract was added.
Comparative example 2
The amount ratio of each component is the same as that of the embodiment 2, and the difference is that a dry granulation method is used, namely, erythritol, dietary fiber (soybean dietary fiber) and protein powder (whey protein), a momordica grosvenori extract (the content of mogroside V is 50.5%), a cyclocarya paliurus extract (the content of total glycosides of cyclocarya paliurus is 80.1%), arabinose and allulose which are used as raw materials in the embodiment 2 in parts by mass are mixed, and the mixture is crushed, sieved and uniformly mixed, and then is made into mixture particles by a dry granulator to obtain the sweet composition.
Application example 1Subjective evaluation of mouthfeel of sweet compositions
1. Screening and training of sensory analysts
Sensory evaluators were screened according to the regulations of GB/T16291.2-2010, and after training for taste sensitivity, 20 sensory evaluators (male and female halves) were finally screened to constitute a sensory evaluation panel.
2. Sensory evaluation method
The organoleptic analysts restricted the diet, especially foods that could seriously affect taste, within 1h before the start of the assessment experiment. After mixing the sweetener compositions obtained in examples with water to make the sweetness close to 2 wt% of sucrose solution, the mixture was prepared into a beverage solution, 10mL of the solution to be evaluated was placed in a disposable paper cup and held in the mouth by a sensory evaluation person, and the solution was discharged after staying for several seconds, with an evaluation time interval of 20 min. Questionnaires are investigated and scored from the taste in the form of questionnaires, each satisfaction degree is 10 points at the maximum, each questionnaire testing person is 12 persons, one highest score is removed, one lowest score is removed, and finally the average value of the whole is obtained.
3. Data processing
The data were subjected to baseline processing by Microsoft Excel and further analysis of variance using SPSS 19.0 software, with the results shown in table 1 below:
TABLE 1
Figure BDA0002744594190000081
Figure BDA0002744594190000091
Application example 2Evaluation of blood lipid-lowering action of sweet taste composition
To confirm that the sweet taste composition provided by the present invention has the effect of reducing blood lipid, the following tests were performed:
the experimental animal is SD rat provided by animal experiment research center of Hunan university of traditional Chinese medicine.
80 healthy SD rats, each half of male and female, weighing 180-. Feeding SD rat to be tested with feed for 4 weeks in normal conditions of temperature (25 + -2 deg.C), sunshine (12 hr) and sleep within normal range, and feeding normal group with common feed (100% basal feed); the control group and the model group were fed with high ester feed (2% cholesterol, 10% lard, 88% basal feed), and the model group was fed with the sweet composition of examples 1-4 of the present invention and comparative examples 1-2 (the amount of gastric feeding was 3 times per day at a dose of 5mg/kg of cyclocarya paliurus extract, and the sweet composition of the present invention was fed with gastric feeding 1 hour after the high ester feed) in addition to the high ester feed. After the last gastric feeding, fasting was performed for 12 hours, the anesthetized rats were bled from the eye, the serum was separated, and TC and GC were tested by the kit method. The TC (total cholesterol), TG (total triglyceride) kit was produced by Santa Hunan, Biotechnology Ltd, and the test results were averaged and are shown in the following Table 2:
TABLE 2
Figure BDA0002744594190000092
Figure BDA0002744594190000101
*P＜0.05，**P＜0.01
The fructus momordicae extract does not have the effect of reducing blood fat per se, and the cyclocarya paliurus extract has a certain effect of reducing blood fat. As can be seen from the data in table 2, the composition formulated with the extract of momordica grosvenori by gastric feeding the sweet composition of the present invention to rats at the same dosage of the extract of cyclocarya paliurus can achieve better blood lipid lowering effect than the sweet composition administered with the extract of cyclocarya paliurus alone (comparative example 1), indicating that the extract of momordica grosvenori and the extract of cyclocarya paliurus produce synergistic effect with each other.

Claims (10)

1. A sweet taste composition for reducing blood lipid comprises filled sweetener, dietary fiber, protein powder, sucrose substitute, fructus Siraitiae Grosvenorii extract and cyclocarya paliurus extract.
2. The blood fat reducing sweet taste composition as claimed in claim 1, wherein the content of mogroside V in the Luo Han Guo extract is above 40% by mass, and the content of cyclocarya paliurus total glycosides in the cyclocarya paliurus extract is above 70% by mass.
3. The hpyerglycemic composition of claim 1, wherein the lo han guo extract and the cyclocarya paliurus extract independently comprise 1 to 5 wt% of the hpyerglycemic composition.
4. The blood fat reducing sweet composition of claim 3, wherein the momordica grosvenori extract accounts for 2-3.5 wt% of the blood fat reducing sweet composition, and the cyclocarya paliurus extract accounts for 1.4-2.6 wt% of the blood fat reducing sweet composition.
5. The blood fat reducing sweet taste composition according to claim 1, wherein the mass ratio of the momordica grosvenori extract to the cyclocarya paliurus extract in the composition is 1:0.6-1.4, preferably 1: 0.8-0.9.
6. The blood fat reducing sweet taste composition according to claim 1, which consists of the following raw materials: erythritol, dietary fiber, protein powder, fructus momordicae extract, cyclocarya paliurus extract, arabinose and psicose.
7. The blood fat reducing sweet taste composition according to claim 6, wherein the sweet taste composition is prepared from the following raw materials in parts by weight: 10-30 parts of erythritol, 10-20 parts of dietary fiber, 8-15 parts of protein powder, 1-2 parts of a momordica grosvenori extract, 1-2 parts of a cyclocarya paliurus extract, 1-5 parts of arabinose and 1-5 parts of allulose.
8. Method for the preparation of a sweetening composition according to any one of claims 1 to 7 comprising the steps of:
(1) and (3) dry granulation: mixing the raw material filled sweetener, the dietary fiber and the protein powder in proportion, crushing, sieving, uniformly mixing, and preparing the mixture of the raw material filled sweetener, the dietary fiber and the protein powder into mixture granules by using a dry-method granulator;
(2) preparation of the adhesive: mixing fructus Siraitiae Grosvenorii extract, cyclocarya paliurus extract, and sucrose substitute at a certain proportion, dissolving in hot water, filtering with ceramic membrane, vacuum concentrating the filtrate under reduced pressure, and keeping the temperature to obtain binder;
(3) boiling and granulating: putting the mixture particles obtained in the step (1) into a fluidized bed of a boiling granulator, starting a fan and heating; spraying the adhesive in the step (2), and keeping the materials in the fluidizing chamber to be boiled and mixed to make the materials uniform; after the spraying of the adhesive is finished, the mixture is dried by heat preservation, stopped and kept stand for cooling, and the sweet composition is obtained.
9. The preparation method of claim 8, wherein the amount of the hot water is 10-20 times of the total mass of the momordica grosvenori extract, the cyclocarya paliurus extract and the sucrose substitute; the temperature of the hot water is 60-80 ℃.
10. The method according to claim 8, wherein in the step (2), the ceramic membrane has a pore size of 0.5 to 10 μm; the vacuum reduced pressure concentration conditions comprise: the temperature is 60-80 ℃, the vacuum degree is-0.07-0.09 MPa, and the concentration is carried out until the solid content is 20-40%; the temperature of the heat preservation is 90-100 ℃, and the time is 1-2 hours; in the step (3), the heating temperature is 100-120 ℃, and the mixing time is 30-60 min.
CN202011161827.2A 2020-10-27 2020-10-27 Sweet composition for reducing blood fat and preparation method thereof Pending CN112120204A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN202011161827.2A CN112120204A (en) 2020-10-27 2020-10-27 Sweet composition for reducing blood fat and preparation method thereof
PCT/CN2021/074139 WO2022088540A1 (en) 2020-10-27 2021-01-28 Blood lipid-lowering sweetener composition and preparation method therefor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011161827.2A CN112120204A (en) 2020-10-27 2020-10-27 Sweet composition for reducing blood fat and preparation method thereof

Publications (1)

Publication Number Publication Date
CN112120204A true CN112120204A (en) 2020-12-25

Family

ID=73852771

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011161827.2A Pending CN112120204A (en) 2020-10-27 2020-10-27 Sweet composition for reducing blood fat and preparation method thereof

Country Status (2)

Country Link
CN (1) CN112120204A (en)
WO (1) WO2022088540A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114304587A (en) * 2021-12-29 2022-04-12 亿利耐雀生物科技有限公司 Compound sweetener containing allulose and preparation method thereof
CN114651988A (en) * 2022-03-23 2022-06-24 浙江科露宝食品有限公司 Protein component formula food for special medical application and preparation method thereof
CN116172208A (en) * 2022-08-17 2023-05-30 广东医科大学 Psicose composition for promoting sleep and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106176953A (en) * 2015-04-29 2016-12-07 无限极（中国）有限公司 A kind of Hyperglycemic health care compositions comprising leaf of Cyclocarya paliurus Iljinskaja, Fructus Momordicae and Folium Mori
CN107280006A (en) * 2017-06-30 2017-10-24 武汉市百锐纳思生物科技有限公司 It is a kind of that there is hypoglycemic, blood fat reducing function composition, beverage and its application
CN108935842A (en) * 2018-06-28 2018-12-07 华南农业大学 A kind of preparation and application of balsam pear blue or green money willow lipid-lowering health-care tea
CN110506922A (en) * 2019-09-24 2019-11-29 湖南艾达伦科技有限公司 A kind of Siraitia grosvenorii compound sweetener and preparation method thereof for stabilizing blood glucose

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102960520B (en) * 2012-11-29 2014-10-29 山东福田科技集团有限公司 L-arabinose health-care press candy added with cyclocarya paliurus
CN106177477A (en) * 2015-04-29 2016-12-07 无限极（中国）有限公司 A kind of health composition for blood sugar lowering, blood fat reducing and blood pressure lowering
CN107223969A (en) * 2017-06-21 2017-10-03 防城港圣保堂制药有限公司 A kind of ion VC compositions containing blue or green money willow and preparation method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106176953A (en) * 2015-04-29 2016-12-07 无限极（中国）有限公司 A kind of Hyperglycemic health care compositions comprising leaf of Cyclocarya paliurus Iljinskaja, Fructus Momordicae and Folium Mori
CN107280006A (en) * 2017-06-30 2017-10-24 武汉市百锐纳思生物科技有限公司 It is a kind of that there is hypoglycemic, blood fat reducing function composition, beverage and its application
CN108935842A (en) * 2018-06-28 2018-12-07 华南农业大学 A kind of preparation and application of balsam pear blue or green money willow lipid-lowering health-care tea
CN110506922A (en) * 2019-09-24 2019-11-29 湖南艾达伦科技有限公司 A kind of Siraitia grosvenorii compound sweetener and preparation method thereof for stabilizing blood glucose

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114304587A (en) * 2021-12-29 2022-04-12 亿利耐雀生物科技有限公司 Compound sweetener containing allulose and preparation method thereof
CN114304587B (en) * 2021-12-29 2024-05-03 亿利耐雀生物科技有限公司 Compound sweetener containing psicose and preparation method thereof
CN114651988A (en) * 2022-03-23 2022-06-24 浙江科露宝食品有限公司 Protein component formula food for special medical application and preparation method thereof
CN116172208A (en) * 2022-08-17 2023-05-30 广东医科大学 Psicose composition for promoting sleep and preparation method thereof
CN116172208B (en) * 2022-08-17 2024-05-28 广东医科大学 Psicose composition for promoting sleep and preparation method thereof

Also Published As

Publication number Publication date
WO2022088540A1 (en) 2022-05-05

Similar Documents

Publication Publication Date Title
JP7086446B2 (en) Steviol Glycoside Purification Method and Its Use
JP6779287B2 (en) Steviol glycoside sweetener with improved flavor profile
CN111031805B (en) Sweetness and taste improvement of dihydrochalcones on steviol glycosides and mogroside sweeteners
JP2021191292A (en) Method of preparing composition imparted with sweetness by adding sweetener incorporating rebaudioside n
US11464250B2 (en) Natural compound sweetener and preparation method therefor
CN112120204A (en) Sweet composition for reducing blood fat and preparation method thereof
CN100502689C (en) Sweetener added with momordica grosvenori extract and its preparing method
JP5568806B2 (en) Diabetes or diabetes complication preventive
EP1757324A2 (en) Agent for preventing, improving or treating hypertension
JP2006045212A (en) Oral composition containing specific quinic acid derivative
CN111295101B (en) Oral sweetener compositions and methods
CN110037280A (en) Compound sweetener low in calories and preparation method thereof
WO2005112665A1 (en) Composition containing processed sweet potato foliage
CN104957472A (en) Sugarless sweetening agent and preparation method thereof
JP4037035B2 (en) Flavor improver
JP5597811B2 (en) Powdered sweetener containing rahan fruit extract powder and reduced indigestible dextrin and method for producing the rahan fruit extract powder
CN113710262B (en) Scutellaria baicalensis composition and method for taste modulation
JP2013169204A (en) Sugar substitute sweetener
JP2006045213A (en) Oral composition containing specific quinic acid derivative
JP2003310212A (en) Composition of water-dispersible or water-soluble leaf extract from lagerstroemia speciosa
KR100688425B1 (en) A COMPOSITION CONTAINING GENSENOSIDE Rh2 AS AN ACTIVE MATERIAL FOR PREVENTING BRAIN CELL
KR100759772B1 (en) A COMPOSITION CONTAINING GENSENOSIDE Rh2 AS AN ACTIVE MATERIAL FOR PREVENTING BRAIN CELL
JP2017043610A (en) Agent for preventing or ameliorating hangover and agent for ameliorating liver function
CN110710672A (en) Natural plant active calcium preparation and preparation method thereof
JP2007070265A (en) Composition for improving lipid metabolism

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20201225